| Title |
Chemotherapy wafers for high grade glioma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2011
|
| DOI | 10.1002/14651858.cd007294.pub2 |
| Pubmed ID | |
| Authors |
Michael G Hart, Ruth Garside, Gabriel Rogers, Margaret Somerville, Ken Stein, Robin Grant |
| Abstract |
Standard treatment for high grade glioma (HGG) usually entails surgery (either biopsy or resection) followed by radiotherapy plus or minus temozolomide. Implanting wafers impregnated with chemotherapy agents into the resection cavity represents a novel means of delivering drugs directly to the resection cavity with potentially fewer systemic side effects. It is not clear how effective this modality is or whether it should be recommended as part of standard care for patients with HGG. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 232 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| Nepal | 1 | <1% |
| Unknown | 229 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 34 | 15% |
| Student > Master | 31 | 13% |
| Student > Bachelor | 30 | 13% |
| Researcher | 27 | 12% |
| Other | 13 | 6% |
| Other | 44 | 19% |
| Unknown | 53 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 92 | 40% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 7% |
| Nursing and Health Professions | 14 | 6% |
| Agricultural and Biological Sciences | 12 | 5% |
| Neuroscience | 11 | 5% |
| Other | 26 | 11% |
| Unknown | 61 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2013.
All research outputs
#17,682,134
of 22,701,287 outputs
Outputs from Cochrane database of systematic reviews
#11,272
of 12,310 outputs
Outputs of similar age
#94,295
of 108,087 outputs
Outputs of similar age from Cochrane database of systematic reviews
#85
of 94 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,310 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,087 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.